Literature DB >> 25169892

Prevalence, incidence, and comorbidity of clinically diagnosed obsessive-compulsive disorder in Taiwan: a national population-based study.

Li-Chung Huang1, Kuen-Jer Tsai2, Hao-Kuang Wang3, Pi-Shan Sung4, Ming-Hsiu Wu5, Kuo-Wei Hung6, Sheng-Hsiang Lin7.   

Abstract

Obsessive-compulsive disorder (OCD) is a chronic debilitating anxiety disorder significant in intrusive thoughts and compensation repetitive behaviors. Few studies have reported on this condition Asia. This study estimated the prevalence, incidence and psychiatric comorbidities of OCD in Taiwan. We identified study subjects for 2000-2008 with a principal diagnosis of OCD according to the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) diagnostic criteria by using National Health Research Institute database. These patients received either outpatient or inpatient care for their condition. Rates were directly age- and sex-adjusted to the 2004 Taiwan population distribution. The estimated mean annual incidence was 27.57 per 10(5) inhabitants and the one year prevalence was 65.05 per 10(5) inhabitants. Incidence and prevalence increased with age, peaking at age 18-24 years in males and at 35-44 years in females. About 53% of adults (≥18 years) and 48% of child and adolescent patients (6-17 years) had one or more comorbid psychiatric conditions. The most common comorbid diagnosis was depressive disorders for both adult and child-adolescent patients. We found a lower prevalence and incidence of clinically diagnosed OCD than that of community studies. Many Asian patients with OCD also had various psychiatric comorbidities, a clinically relevant finding.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Comorbidity; Incidence; National Health Insurance; Obsessive and compulsive disorder; Prevalence; Taiwan

Mesh:

Year:  2014        PMID: 25169892     DOI: 10.1016/j.psychres.2014.08.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Subclinical autism spectrum symptoms in pediatric obsessive-compulsive disorder.

Authors:  Trine Wigh Arildskov; David R M A Højgaard; Gudmundur Skarphedinsson; Per Hove Thomsen; Tord Ivarsson; Bernhard Weidle; Karin Holmgren Melin; Katja A Hybel
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-10-30       Impact factor: 4.785

2.  Incidence Rates and Cumulative Incidences of the Full Spectrum of Diagnosed Mental Disorders in Childhood and Adolescence.

Authors:  Søren Dalsgaard; Erla Thorsteinsson; Betina B Trabjerg; Jörg Schullehner; Oleguer Plana-Ripoll; Isabell Brikell; Theresa Wimberley; Malene Thygesen; Kathrine Bang Madsen; Allan Timmerman; Diana Schendel; John J McGrath; Preben Bo Mortensen; Carsten B Pedersen
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

3.  Register-based study of the incidence, comorbidities and demographics of obsessive-compulsive disorder in specialist healthcare.

Authors:  Hanna Rintala; Roshan Chudal; Sami Leppämäki; Susanna Leivonen; Susanna Hinkka-Yli-Salomäki; Andre Sourander
Journal:  BMC Psychiatry       Date:  2017-02-10       Impact factor: 3.630

4.  Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review.

Authors:  Chiara Rapinesi; Georgios D Kotzalidis; Stefano Ferracuti; Gabriele Sani; Paolo Girardi; Antonio Del Casale
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

5.  Increased Risk of Sjögren's Syndrome in Patients with Obsessive-Compulsive Disorder: A Nationwide Population-Based Cohort Study.

Authors:  Yi-Jung Chang; Jui-Cheng Tseng; Pui-Ying Leong; Yu-Hsun Wang; James Cheng-Chung Wei
Journal:  Int J Environ Res Public Health       Date:  2021-06-01       Impact factor: 3.390

6.  Autism Spectrum Symptoms in Children and Adolescents with Obsessive Compulsive Disorder and Their Mothers.

Authors:  Gonca Özyurt; Lütfullah Beşiroğlu
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.